Effective antibiotic regime for postoperative acute cholangitis in biliary atresia - An evolving scene

Journal of Pediatric Surgery

Volumn 39, Issue 12, 2004, Pages 1800-1802

  Wong, Kenneth K Y ^a   Fan, Alex H ^a   Lan, Lawrence C L ^a   Lin, Steve C L ^a   Tam, Paul K H ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

antibiotics; Biliary atresia; cholangitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFOPERAZONE; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; GENTAMICIN; LIVER ENZYME; MEROPENEM; TICARCILLIN;

ARTICLE; BILE DUCT ATRESIA; CHOLANGITIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; FEVER; HUMAN; INFORMATION PROCESSING; PORTOENTEROSTOMY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BILIARY ATRESIA; CEFOPERAZONE; CHILD; CHOLANGITIS; HUMANS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 10944242334     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2004.08.027     Document Type: Article

References (19)

1. Haber B.A., Russo P. Biliary atresia. Gastroenterol Clin North Am. 32:2003;891-911
2. Kasai M., Suzuki S. A new operation for "non-correctable" biliary atresia Hepatic portoenterostomy. Shujjutsu. 13:1959;733
3. Kobayashi A., Itabashi F., Ohbe Y. Long-term prognosis in biliary atresia after hepatic portoenterostomy Analysis of 35 patients who survived beyond 5 years of age. J Pediatr. 105:1984;243-246
4. Van Heurn E.L.W., Saing H., Tam P.K. Cholangitis after hepatic portoenterostomy for biliary atresia A multivariate analysis of risk factors. J Pediatr. 142:2003;566-571
5. Kobayashi A., Utsunomiya T., Obe Y., et al. Ascending cholangitis after successful surgical repair of biliary atresia. Arch Dis Child. 48:1973;697-703
6. Lunzmann K., Schweizer P. The influence of cholangitis on the prognosis of extrahepatic biliary atresia. Eur J Pediatr Surg. 9:1999;19-23
7. Wildhaber B.E., Coran A.G., Drongowski R.A., et al. The Kasai portoenterostomy for biliary atresia A review of a 27-year experience with 81 patients. J Pediatr Surg. 38:2003;1480-1485
8. Nakajo T., Hashizume K., Saeki M., et al. Intussusception-type antireflux valve in the Roux-en-Y loop to prevent ascending cholangitis after hepatic portojejunostomy. J Pediatr Surg. 25:1990;311-314
9. Tanaka K., Shirahase I., Utsunomiya H., et al. A valved hepatic portoduodenal intestinal conduit for biliary atresia. Ann Surg. 213:1991;230-235
10. Chuang J.H., Lee S.Y., Shieh C.S., et al. Reappraisal of the role of the bilioenteric conduit in the pathogenesis of postoperative cholangitis. Pediatr Surg Int. 16:2000;29-34
11. Chaudhary S., Turner R.B. Trimethoprim-sulfamethoxazole for cholangitis following hepatic portoenterostomy for biliary atresia. J Pediatr. 99:1981;656-658
12. Bu L.N., Chen H.L., Chang C.J., et al. Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy. J Pediatr Surg. 38:2003;590-593
13. Saing H., Tsang T.M., Tam P.K.H., et al. A prospective randomized trial comparing cefoperazone versus ampicillin-gentamicin-metronidazole in the empirical treatment of postoperative cholangitis in biliary atresia. Proceedings of the 5th International Sendai Symposium on Biliary Atresia. 1991;176-181
14. Cunha B.A. Antibiotic resistance Control strategies. Crit Care Clin. 14:1998;309-327
15. Leclercq R. Safeguarding future antimicrobial options Strategies to minimize resistance. Clin Microbiol Infect. 7:(Suppl 3):2001;18-23
16. Hall C.S., Ost D.E. Effectiveness of programs to decrease antimicrobial resistance in the intensive care unit. Semin Respir Infect. 18:2003;112-121
17. Edwards J.R., Turner P.J., Wannop C., et al. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I. Antimicrob Agents Chemother. 33:1989;215-222
18. Nord C.E., Lindmark A., Persson I. Susceptibility of anaerobic bacteria to meropenem. J Antimicrob Chemother. 24:(Suppl A):1989;113-117
19. Granai F., Smart H.L., Triger D.R. A study of the penetration of meropenem into bile using endoscopic retrograde cholangiography. J Antimicrob Chemother. 29:1992;711-718